ReviewRSC advances2021
Chemistry and biological activities of hetisine-type diterpenoid alkaloids.
Review in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 20 citations in OpenAlex.
- Study of Anxiolytic Properties of Diterpene Alkaloid 12-Epinapelline N-Oxide.Bulletin of experimental biology and medicine · 2026Article
- Anticonvulsant Activity of 12-Epinapelline N-Oxide, a Diterpene Alkaloid of the Atisine Series.Bulletin of experimental biology and medicine · 2025Article
- Azine Dearomatization in Natural Product Total Synthesis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Review
- Antiviral Potential ofFoods (Basel, Switzerland) · 2024Article
- Overview of the chemistry and biological activities of natural atisine-type diterpenoid alkaloids.RSC advances · 2024Review
- Exploring the Biomedical Potential of Terpenoid Alkaloids: Sources, Structures, and Activities.Molecules (Basel, Switzerland) · 2024Review
- The Chemical Ecology of Plant Natural Products.Progress in the chemistry of organic natural products · 2024Review
- Finding activity through rigidity: syntheses of natural products containing tricyclic bridgehead carbon centers.Natural product reports · 2023Review
- Network pharmacology combined with molecular docking andFrontiers in pharmacology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hetisine-type C
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.